Theranostics 2018; 8(21):5890-5902. doi:10.7150/thno.27667 This issue Cite

Research Paper

BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1

Panpan Zhang1#, Shaolei Li1#, Chao Lv1, Jiahui Si1, Ying Xiong1, Lieming Ding2, Yuanyuan Ma1✉, Yue Yang1✉

1. Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
2. Betta Pharmaceuticals Co., Ltd, No. 589 Hongfeng Road, Yuhang Economic and Technological Development Area, Hangzhou, China
# Panpan Zhang and Shaolei Li contributed equally to this work.

Citation:
Zhang P, Li S, Lv C, Si J, Xiong Y, Ding L, Ma Y, Yang Y. BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. Theranostics 2018; 8(21):5890-5902. doi:10.7150/thno.27667. https://www.thno.org/v08p5890.htm
Other styles

File import instruction

Abstract

Graphic abstract

Activation of c-Met plays a critical role in tumorigenesis, migration and invasion in lung cancer. Here, we explored the therapeutic efficacy of a novel small-molecule c-Met inhibitor (BPI-9016M) in lung adenocarcinoma and investigated the underlying molecular mechanisms.

Method: BPI-9016M, a c-Met tyrosine kinase receptor inhibitor, was used to treat patient-derived xenografts (PDX) from lung adenocarcinoma in NOD/SCID mice. Immunohistochemistry and Western blot analysis were used to determine the expression of c-Met and its downstream signaling molecules. CCK8, wound healing, and trans-well assays were used to analyze cell proliferation, spreading, migration and invasion. RNA sequencing and quantitative real-time PCR (qPCR) was used to screen and validate the expression of downstream genes in lung adenocarcinoma cells treated with BPI-9016M. Luciferase reporter assay was used to detect the interaction between miRNA and the targeted gene.

Results: BPI-9016M significantly suppressed growth in three out of four lung adenocarcinoma PDX models, particularly in the tumors with high expression of c-Met. In lung adenocarcinoma cell lines, BPI-9016M treatment resulted in increased miR203, which reduced migration and invasion and also repressed Dickkopf-related protein 1 (DKK1) expression. Forced overexpression of DKK1 or down-regulation of miR203 reversed the inhibitory effect of BPI-9016M on migration and invasion. C-Met was verified to positively and negatively associate with DKK1 and miR203, respectively. High expression of c-Met/DKK1 or low expression of miR203 related to poor outcome of lung adenocarcinoma patients. Furthermore, we observed significantly enhanced tumor cell growth inhibition upon combining BPI-9016M treatment with miR203 mimics or DKK1 siRNA.

Conclusion: Our data indicated that BPI-9016M is an effective agent against lung adenocarcinoma, particularly in tumors with c-Met activation, and likely functions through upregulation of miR203 leading to reduced DKK1 expression.

Keywords: lung adenocarcinoma, BPI-9016M, c-Met, miR203, Dickkopf-1 (DKK1)


Citation styles

APA
Zhang, P., Li, S., Lv, C., Si, J., Xiong, Y., Ding, L., Ma, Y., Yang, Y. (2018). BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. Theranostics, 8(21), 5890-5902. https://doi.org/10.7150/thno.27667.

ACS
Zhang, P.; Li, S.; Lv, C.; Si, J.; Xiong, Y.; Ding, L.; Ma, Y.; Yang, Y. BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. Theranostics 2018, 8 (21), 5890-5902. DOI: 10.7150/thno.27667.

NLM
Zhang P, Li S, Lv C, Si J, Xiong Y, Ding L, Ma Y, Yang Y. BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. Theranostics 2018; 8(21):5890-5902. doi:10.7150/thno.27667. https://www.thno.org/v08p5890.htm

CSE
Zhang P, Li S, Lv C, Si J, Xiong Y, Ding L, Ma Y, Yang Y. 2018. BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. Theranostics. 8(21):5890-5902.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image